OAKLAND, Calif. — Electricity is still hot.
The much-hyped field of “electroceuticals” — which involves zapping nerves with tiny electrical pulses to treat disease — got another injection of funds late last month with a $30 million investment round for startup SetPoint Medical.
Major medical device companies Medtronic and Boston Scientific kicked in funding, as did several venture funds. Global pharma giant GlaxoSmithKline has also invested in SetPoint.
